Our partners

The Triple Chasm Company empowers successful commercialisation of science & tech-enabled innovation

We provide a range of books, tools, programmes and bespoke services based on the Triple Chasm Model® (TCM) that are designed to help those involved in the commercialisation of innovation to achieve their ambitions.

Based on initial research into 3000 products being taken to market, the Triple Chasm Model® (TCM) provides a comprehensive underpinning commercialisation framework including a measure of commercialisation maturity (Commercialisation Readiness Level), the 12 factors that influence growth (Meso-economic Vectors), and the commercialisation journey that maps out which Meso-economic Vectors matter at which stage of the journey – the Commercialisation Readiness Level.

NHS East Genomics is the umbrella name for the East Genomic Laboratory Hub (GLH) and East Genomic Medicine Service Alliance (GMSA).

East GLH

The East Genomic Laboratory Hub (East GLH) provides and coordinates genomic tests for rare and inherited diseases, cancer and haematological malignancy within the East of England and East Midlands. It is one of seven English hubs which together make up the national genomic laboratory service.  East GLH provides tests listed in the National Genomic Test Directory. Their lead laboratory is based at Cambridge University Hospitals NHS Foundation Trust. This is supported by local genomic laboratories based at University Hospitals Leicester NHS Trust and Nottingham University Hospitals NHS Trust. Find out more here.

East GMSA

East Genomic Medicine Service Alliance (GMSA) has been set up to ensure all eligible patients across the East Midlands and East of England can access and benefit from appropriate genomic tests when required, ensuring high-quality and personalised treatment. Their remit includes transformation projects, research and innovation, workforce development, patient and public involvement and engagement and Genomic Networks of Excellence. Find out more here.

GaitSmart is an innovative digital health solution used in clinics to help people with mobility issues due to a musculoskeletal condition without the need of a highly qualified physiotherapist.  It has been designed to be used by a healthcare assistant (HCA) to provide gait analysis and a gait rehabilitation programme in a 10 minute test.

The GaitSmart measurement drives the rehabilitation programme and a further measurement demonstrates the effectiveness of the intervention.  It can help in the diagnosis and treatment in primary, secondary and community care.

Officially launched in 2021, the Norwich Institute of Healthy Ageing (NIHA) develops and implements effective strategies to promote sustained population behaviour change, in order to improve physical and mental well-being.

A multi-agency, multi-disciplinary research unit, one of the core interests of NIHA is establishing the impact of nutrition, physical activity, sleep and smoking status on health outcomes, and how to deliver effective behaviour change interventions.

Our research contributes to the UK Healthy Ageing Grand Challenge to increase healthy life expectancy by 5 years by 2035, while narrowing the gap between the experience of the richest and poorest

NHS Norfolk and Waveney Integrated Care Board (ICB) plans and buys healthcare services for our local population and is accountable for the performance and finances of the NHS across Norfolk and Waveney. The organisation works with local people, health and care professionals, and partner organisations to improve the health and wellbeing of our population. The ICB is part of the Norfolk and Waveney Integrated Care System; a system dedicated to working with partners in local government, the voluntary sector and others and helping the NHS to support broader social and economic development and to tackle inequalities in health outcomes.

Innovation is integral to the ICB, by working together with Health Innovation East, the ICB will be a leader in implementing health innovations. Health Innovation East will support the ICB to identify innovation opportunities, implementation, evaluation, adoption, spread and sustainment.

Our Partnership is expanding the region’s capacity for high quality collaborative research and innovation to address the most pressing challenges affecting our population health and wellbeing.

We work with practitioners, clinicians, and academic researchers working in Health and Social Care to help maximise research impact.

Start Codon is a venture-building fund that Discovers, Nurtures and Advances next-generation healthcare and life science companies. They provide pre-seed funding alongside a bespoke venture-building programme and support from their experienced team, to help create thriving companies that improve people’s lives and address unmet needs.

A collaborative entrepreneurial community of technology start-ups and scale-ups. Our aim is to attract ambitious like-minded entrepreneurs from both Cambridge and around the world; co-locate them in scalable, state-of-the-art facilities; immerse them in a vibrant, collaborative, and inclusive culture; whilst connecting them to investors and other support organisations to help them grow.

The Wellcome Sanger Institute is a world leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our blog.

The Babraham Research Campus is a leading location which supports early-stage bioscience enterprise and is distinct in its co-location of bioscience companies with the world leading discovery research of the Babraham Institute. Our Campus is a dynamic environment, home to over 60 companies, 2,000 employees and 300 academic researchers. It is where discovery research and business come together with a shared scientific focus that accelerates innovation and strengthens links between academia and the commercial world.